{"id":"NCT00456365","sponsor":"University of Colorado, Denver","briefTitle":"Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)","officialTitle":"Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2012-10","completion":"2012-10","firstPosted":"2007-04-04","resultsPosted":"2018-03-09","lastUpdate":"2018-03-09"},"enrollment":110,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Polycystic Kidney, Autosomal Dominant"],"interventions":[{"type":"DRUG","name":"pravastatin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Pravastatin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether the medication pravastatin will ameliorate renal and cardiovascular disease over a 3-year period in children and young adults with autosomal dominant polycystic kidney disease (ADPKD).","primaryOutcome":{"measure":"Percent of Participants Demonstrating 20% or More Increase in Total Kidney Volume","timeFrame":"3 years","effectByArm":[{"arm":"Pravastatin","deltaMin":69,"sd":null},{"arm":"Placebo","deltaMin":88,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.03"}]},"eligibility":{"minAge":"8 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["16669974","16221221","16129202","15837441","12046022","15533729","39356039"],"seeAlso":["http://www.pkdcure.org"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":56},"commonTop":[]}}